THRX

Theravance, Inc. News Headlines

$15.225
*  
0.905
6.32%
Get THRX Alerts
*Delayed - data as of Dec. 18, 2014  -  Find a broker to begin trading THRX now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    THRX Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Sector Update: Health-Care Shares Flat Pre-Market; Sarepta Soars 75% on New Drug Application Plans for Eteplirsen
4/21/2014 7:18:57 AM - MT Newswires


Why You Should Still Be Considering A Bio-Tech Stock, But With A Sensible Hedge
4/14/2014 9:13:00 AM - Martin Tillier


First Week of THRX April 19th Options Trading
4/7/2014 10:25:08 AM - BNK Invest


Theravance Is A Classic Ben Graham Bargain
4/4/2014 8:25:00 AM - Seeking Alpha


Theravance: Baby Thrown Out With The Bath Water - 35% To 65% Upside
3/31/2014 2:48:00 PM - Seeking Alpha


First Week of May 17th Options Trading For Theravance (THRX)
3/27/2014 12:01:41 PM - BNK Invest


Theravance Larger Than S&P 500 Component International Game Technology
3/26/2014 3:44:06 PM - BNK Invest


Glaxo/Theravance Update on COPD Drugs - Analyst Blog
3/18/2014 5:30:01 PM - Zacks.com


Update on Glaxo's Pipeline - Analyst Blog
3/17/2014 12:53:01 PM - Zacks.com


Theravance to Split in Q2 - Analyst Blog
3/4/2014 12:00:01 PM - Zacks.com


THRX Crosses Below Key Moving Average Level
2/28/2014 4:43:00 PM - BNK Invest


Update on Teva's DuoResp Spiromax - Analyst Blog
2/25/2014 6:00:01 PM - Zacks.com


CHMP Positive on Glaxo's Two Drugs - Analyst Blog
2/21/2014 4:45:01 PM - Zacks.com


Tracking Seth Klarman's Baupost Group Holdings - Q4 2013 Update
2/14/2014 3:01:00 AM - Seeking Alpha


Loss at Theravance Wider Than Expected - Analyst Blog
2/7/2014 12:10:01 PM - Zacks.com


Top 2013 Drug Approvals: Pharma Stocks
1/27/2014 3:58:00 PM - Seeking Alpha


Evoke Pharma Moves Full Speed Ahead
1/26/2014 7:46:00 PM - Seeking Alpha


Theravance Inc. (THRX): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report
1/7/2014 7:00:01 AM - Zacks.com


Glaxo/THRX' Drug Gets FDA Nod - Analyst Blog
12/19/2013 11:10:01 AM - Zacks.com


Healthcare Stocks Staying Near Session Lows; Theravance Gains on Testing for Respiratory Drug
12/17/2013 3:54:32 PM - MT Newswires


Sector Update: Healthcare
12/17/2013 3:51:07 PM - MT Newswires


Positive Data on Glaxo/Theravance Drug - Analyst Blog
12/9/2013 5:06:30 PM - Zacks.com


Glaxo/THRX's Relvar Approved in EU - Analyst Blog
11/19/2013 6:06:01 PM - Zacks.com


Seth Klarman Buys Micron Technology, Theravance, PBF Energy, Sells BP, AIG, Yamana Gold
11/13/2013 6:56:38 PM - GuruFocus


Are You Betting Too Much On Theravance?
11/1/2013 11:28:00 AM - Seeking Alpha